Mitratapide
-
Mitratapide
structure -
-
CAS No:
179602-65-4
-
Formula:
C36H41ClN8O4S
-
Chemical Name:
Mitratapide
-
Synonyms:
3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2S,4R)-2-(4-chlorophenyl)-2-[[(4-methyl-4H-1,2,4-triazol-3-yl)thio]methyl]-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-[(1R)-1-methylpropyl]-;3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[2-(4-chlorophenyl)-2-[[(4-methyl-4H-1,2,4-triazol-3-yl)thio]methyl]-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-,[2S-[2α,4α(S*)]]-;4-[4-[4-[4-[[(2S,4R)-2-(4-Chlorophenyl)-2-[[(4-methyl-4H-1,2,4-triazol-3-yl)thio]methyl]-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-[(1R)-1-methylpropyl]-3H-1,2,4-triazol-3-one;Mitratapide;R 103757;Yarvitan
-
CAS No:
Description
Mitratapide is a microsomal triglyceride transfer protein inhibitor, approved in veterinary use for weight loss and reduction of hyperlipidemia in dogs.
Drug Information
As an aid in the management of overweight and obesity in adult dogs. To be used as part of an overall weight management programme which also includes appropriate dietary changes. Introducing appropriate lifestyle changes (e.g. increased exercise), in conjunction with this weight management programme, may provide additional benefits.
mitratapide
Mitratapide Use and Manufacturing
Veterinary drugs -> Yarvitan -> EMA Drug Category|Antiobesity preparations, excl. diet products -> Veterinary pharmacotherapeutic group
Computed Properties
Molecular Weight:717.3
XLogP3:5.4
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:12
Exact Mass:716.2660007
Monoisotopic Mass:716.2660007
Topological Polar Surface Area:126
Heavy Atom Count:50
Complexity:1130
Defined Atom Stereocenter Count:3
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation